We are live on ! Find out more
JC

Jacobs & Co Portfolio holdings

AUM $1.17B
1-Year Est. Return 37.3%
This Fund
S&P 500
This Quarter Est. Return
+3.88%
1 Year Est. Return
+37.3%
3 Year Est. Return
+92.23%
5 Year Est. Return
+114.23%
10 Year Est. Return
+410.55%
AUM
$448M
AUM Growth
+$22.8M
Cap. Flow
+$6.71M
Cap. Flow %
1.5%
Top 10 Hldgs %
21.81%
Holding
124
New
3
Increased
44
Reduced
55
Closed
5

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.59M
2
NKE icon
Nike
NKE
+$1.05M
3
SBUX icon
Starbucks
SBUX
+$630K
4
ADBE icon
Adobe
ADBE
+$498K
5
V icon
Visa
V
+$355K

Top Sells

Rank Stock Value
1
HAIN icon
Hain Celestial
HAIN
+$894K
2
FMER
FIRSTMERIT CORP
FMER
+$433K
3
GLW icon
Corning
GLW
+$398K
4
CPB icon
Campbell Soup
CPB
+$279K
5
CVS icon
CVS Health
CVS
+$256K

Sector Composition

Rank Sector Weight
1 Healthcare 18.16%
2 Technology 16.92%
3 Communication Services 13.14%
4 Industrials 12.4%
5 Consumer Staples 11.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KHC icon
51
Kraft Heinz
KHC
$30.7B
$3.3M 0.74%
36,893
+2,221
+6% +$197K
CMI icon
52
Cummins
CMI
$87.5B
$3.24M 0.72%
25,313
-208
-0.8% -$25.2K
YUM icon
53
Yum! Brands
YUM
$41.8B
$3.17M 0.71%
48,610
-256
-0.5% -$16.3K
HUB.B
54
DELISTED
HUBBELL INC CL-B
HUB.B
$3.15M 0.7%
29,245
-250
-0.8% -$26.9K
GSK icon
55
GSK
GSK
$104B
$3.12M 0.7%
57,882
+1,644
+3% +$90.1K
KO icon
56
Coca-Cola
KO
$377B
$2.88M 0.64%
68,012
-1,990
-3% -$87.2K
MRK icon
57
Merck
MRK
$322B
$2.86M 0.64%
48,056
-262
-0.5% -$15.3K
AXP icon
58
American Express
AXP
$227B
$2.84M 0.63%
44,320
+1,335
+3% +$85.8K
ADP icon
59
Automatic Data Processing
ADP
$106B
$2.83M 0.63%
32,094
-48
-0.1% -$4.35K
SNA icon
60
Snap-on
SNA
$21.2B
$2.73M 0.61%
17,950
– –
GILD icon
61
Gilead Sciences
GILD
$162B
$2.7M 0.6%
34,088
+148
+0.4% +$12K
BMY icon
62
Bristol-Myers Squibb
BMY
$133B
$2.6M 0.58%
48,138
+24,754
+106% +$1.59M
BUD icon
63
AB InBev
BUD
$170B
$2.42M 0.54%
18,402
-200
-1% -$25.3K
EMR icon
64
Emerson Electric
EMR
$83.9B
$2.39M 0.53%
43,772
-62
-0.1% -$3.32K
BRK.B icon
65
Berkshire Hathaway Class B
BRK.B
$1.1T
$2.38M 0.53%
16,471
– –
BAX icon
66
Baxter International
BAX
$13.5B
$2.37M 0.53%
49,875
-4,400
-8% -$207K
RDS.A
67
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$2.19M 0.49%
43,840
+481
+1% +$24.5K
CAT icon
68
Caterpillar
CAT
$375B
$2.19M 0.49%
24,653
+305
+1% +$25K
EA icon
69
Electronic Arts
EA
$53B
$2.09M 0.47%
24,517
-115
-0.5% -$9.2K
CELG
70
DELISTED
Celgene Corp
CELG
$2.05M 0.46%
19,608
+1,161
+6% +$126K
LH icon
71
Labcorp
LH
$25B
$2.05M 0.46%
17,330
+542
+3% +$63.9K
PNR icon
72
Pentair
PNR
$10.4B
$1.77M 0.4%
41,110
-628
-2% -$26.5K
TWTR
73
DELISTED
Twitter, Inc.
TWTR
$1.72M 0.38%
74,806
-1,155
-2% -$21.7K
INTU icon
74
Intuit
INTU
$86.5B
$1.71M 0.38%
15,499
+2,161
+16% +$242K
KDP icon
75
Keurig Dr Pepper
KDP
$42.3B
$1.56M 0.35%
17,065
-50
-0.3% -$4.74K
1 2
3
4 5

Similar funds

OCAI
O'Connor Alternative Investments New York $1.17B AUM
BONST
Bank of Nova Scotia Trust Toronto, Ontario, Canada $1.16B AUM 27.04% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
FG
Fiduciary Group Savannah, Georgia $1.17B AUM 16.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Jacobs & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Jacobs & Co held 124 positions worth $448M, up 5.4% from $426M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Jacobs & Co's Q3 2016 filing shows 3 new, 44 increased, 55 reduced and 5 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 859 shares worth $345K. The largest sale was Hain Celestial, an estimated $894K.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Communication Services.

  • Jacobs & Co's largest Q3 2016 buy was Regeneron Pharmaceuticals: 859 shares worth $345K.
  • Jacobs & Co added most to Bristol-Myers Squibb in Q3 2016, an estimated $1.59M increase.
  • Jacobs & Co's biggest Q3 2016 reduction was Corning, cutting an estimated $398K.
  • Jacobs & Co fully exited Hain Celestial in Q3 2016, selling an estimated $894K.
  • Jacobs & Co's ten largest holdings make up 22% of its $448M portfolio in Q3 2016.
  • Jacobs & Co opened 3 new positions and closed 5 in Q3 2016.
  • Jacobs & Co's portfolio value rose 5.4% quarter-over-quarter to $448M.

Based on Jacobs & Co's 13F filing for Q3 2016, filed 11 Oct 2016.